Skip to main content
Premium Trial:

Request an Annual Quote

AnPac Bio Plans $5M Private Placement

NEW YORK — Chinese cancer diagnostics firm AnPac Bio-Medical Science said on Monday that it has signed definite agreements to sell $5 million in stock through a private placement.

According to AnPac, it signed agreements with unnamed investors for the sale of 16,666,665 million newly issued ordinary shares at a price of $.30 per share, or $6 per American Depositary Share. The transactions are expected to close late this month.

Proceeds of the placement, AnPac said, will be used for working capital and for the expansion of the company's business-to-business Asian food e-commerce operations in the US.

News of the upcoming private placement comes less than two months after AnPac disclosed that it had received notice that its stock faces delisting from the Nasdaq for the firm's failure to maintain a minimum $2.5 million stockholders' equity.

During early Monday morning trading on the Nasdaq, shares of AnPac were down $.11 at $8.39.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.